Science Explorer Interactive view Map
Company · Toronto · Canada

Augmentium Pharma Consulting (Canada)

augmentium.comROR OpenAlex
Research works
32
▼ 69% vs 2013–17
Citations
295
9.2 per fractional work
Top-10% rate
5.4%
record average 16.5%
Open access
31%
world 28%

Not ranked overall: Augmentium Pharma Consulting (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Augmentium Pharma Consulting (Canada)?

Ranked on the composite score, George Dranitsaris and George Dranitsaris lead among researchers whose main affiliation is Augmentium Pharma Consulting (Canada).

  1. 1 George Dranitsaris Canada · #463,535 worldwide 90 citations · 22 works
  2. 2 George Dranitsaris Canada · #1,457,288 worldwide 9 citations · 17 works
All ranked researchers at Augmentium Pharma Consulting (Canada)

Which keywords describe research at Augmentium Pharma Consulting (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Metastatic Breast Cancer, Clinical Practice Guidelines, Chemotherapy, Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Prophylaxis and Minimal Residual Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Quality of Life5▲ 12×5 topics
  2. Clinical Practice Guidelines3▲ 19×4 topics
  3. Metastatic Breast Cancer3▲ 158×2 topics
  4. Chemotherapy3▲ 14×13 topics
  5. Chemotherapy-Induced Peripheral Neuropathy3▲ 160×1 topic
  6. Taxanes3▲ 160×1 topic
  7. Prophylaxis2▲ 56×2 topics
  8. Minimal Residual Disease2▲ 102×2 topics
  9. Treatment2▲ 5.3×5 topics
  10. Diagnosis2▲ 6.4×3 topics
  11. Cost-effectiveness Analysis2▲ 79×1 topic
  12. Health Utility Measures2▲ 79×1 topic
  13. Antithrombotic Therapy2▲ 57×2 topics
  14. Neoadjuvant Therapy2▲ 25×3 topics
  15. Breast Cancer2▲ 19×4 topics
  16. Diagnosis Criteria2▲ 172×1 topic
  17. International Myeloma Working Group2▲ 172×1 topic
  18. Molecular Subtypes2▲ 62×2 topics
  19. Radiotherapy2▲ 14×4 topics
  20. Risk Factors2▲ 5.1×3 topics
  21. Pulmonary Embolism2▲ 73×1 topic
  22. Venous Thromboembolism2▲ 73×1 topic
  23. Clinical Trials2▲ 7.7×6 topics
  24. Cost of Care2▲ 245×1 topic
  25. Financial Toxicity2▲ 245×1 topic
  26. Prognostic Markers2▲ 51×2 topics
  27. Survival Analysis2▲ 17×3 topics
  28. Breast Tumours1▲ 87×1 topic
  29. Gene Expression1▲ 7.4×2 topics
  30. Management1▲ 5.6×6 topics
  31. Treatment Response1▲ 87×1 topic
  32. Guidelines1▲ 8.7×5 topics
  33. Cancer1▲ 2.5×2 topics
  34. Immunotherapy1▲ 5.5×6 topics
  35. Pharmaceutical Industry1▲ 84×2 topics
  36. Targeted Therapy1▲ 17×4 topics
  37. Tumor Microenvironment1▲ 9.8×4 topics
  38. Inflammation1▲ 1.34×8 topics

Which research topics does Augmentium Pharma Consulting (Canada) publish most on?

By volume in 2022–2025: Eosinophilic Disorders and Syndromes, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.

Eosinophilic Disorders a…0Eosinophilic Disorders and Syndromes: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksLung Cancer Diagnosis an…0Lung Cancer Diagnosis and Treatment: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksNausea and vomiting mana…0Nausea and vomiting management: 0 fractional works
RheumatologyPulmonary and Respiratory MedicineOncologySurgery

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Eosinophilic Disorders and Syndromes Rheumatology 0 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  3. 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
  4. 4 Lung Cancer Research Studies Oncology 0 works
  5. 5 Nausea and vomiting management Surgery 0 works
  6. 6 Pathogenesis and Treatment of Hiccups Physiology 0 works
  7. 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 0 works
  8. 8 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Enhanced Recovery After Surgery Surgery 0 works
  10. 10 Chemotherapy-induced organ toxicity mitigation Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.9%not open69.1%

World: 28% of research is openly available.

with international co-authors53.6%domestic only46.4%

World: 19% is written across borders.

How has Augmentium Pharma Consulting (Canada)'s research output changed?

Output in 2018–2022 was 69% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Toronto

All research institutions in Toronto

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.